Publications by authors named "Isabelle Durieu"

Claim this Profile
F
Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study.
Anne Murarasu, Lauren Beaudeau, Veronique Le Guern, Gaelle Guettrot-Imbert, Claire Cazalets, Isabelle Durieu

Lancet Rheumatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sweat chloride and lung function responses to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studies.
Pierre-Régis Burgel, Jennifer Da Silva, Emmanuelle Girodon, Isabelle Durieu, Martine Reynaud-Gaubert

Lancet Respir Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intervention mapping for the development of a new model of care for people with cystic fibrosis in the era of highly effective modulator therapy.
Julie Haesebaert, Quitterie Reynaud, Isabelle Durieu, Stephanie Poupon-Bourdy, Thierry Nouvel

Arch Pediatr· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Variant in CTLA4 Highlights the Heterogeneous Phenotype of CTLA4 Haploinsufficiency.
Jonathan Sormani, Alexandre Belot, Raphaele Nove-Josserand, Capucine Picard, Jérémie Rosain, Isabelle Durieu

J Clin Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR.
Iwona Pranke, Valeria Capurro, Benoit Chevalier, Emanuela Pesce, Valeria Tomati, Isabelle Durieu

Front Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous glucose monitoring is a better indicator of glucose tolerance than HbA1c in cystic fibrosis.
Laure Alexandre-Heymann, Quitterie Reynaud, Caroline Grou, Valérie Boudreau, Valérie Parent, Isabelle Durieu

J Cyst Fibros· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial.
Isabelle Durieu, Barry Clements, Benedetta Fabrizzi, Marcus A Mall, Edward McKone

Am J Respir Crit Care Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.
Yoann Zadro, Amélie Lusque, Héloïse Rey, Pierre Cougoul, Jérémie Dion, Isabelle Durieu

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Severe anemia in a 44-year-old woman].
Marie Meignien, Romain Euvrard, Yoann Roubertou, Mael Richard, Natacha Grienay-Poletto, Isabelle Durieu

Rev Med Interne· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Internal medicine: A core discipline in healthcare establishments for the care of complex patients].
Quitterie Reynaud, Mathias Gernez, Natacha Grienay-Poletto, Pascal Sève, Arnaud Hot, Isabelle Durieu

Rev Med Interne· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): results of a multicentre randomised controlled trial.
Barry J Plant, Gisli G Einarsson, Kevin F Deasy, Darren Dahly, Pradeep K Singh, Isabelle Durieu

Eur Respir J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of anti-CCP2 and anti-DNA antibodies: Clinical features of 79 patients.
Axel Tabary, Frédéric Coutant, Fabien Subtil, Pascal Sève, Arnaud Hot, Isabelle Durieu

Joint Bone Spine· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of iron status with elexacaftor tezacaftor ivacaftor therapy is associated with the correction of systemic inflammation and improvement of lung function: a one-year prospective study.
Hervé Lobbes, Bruno Pereira, Maël Richard, Marie Roux-Perceval, Isabelle Durieu

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newborn Screening for Cystic Fibrosis Is Associated With the Lowest Healthcare Costs: A 10-Year Observational Follow-Up Study in France.
Erika Guyot, Floriane Deygas, Manon Belhassen, Marjorie Berard, Eric Van Ganse, Isabelle Durieu

Pediatr Pulmonol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isavuconazole off-label use as an empirical treatment of invasive fungal infections.
Anne-Lise Bienvenu, Chloe Gasser, Sophie Ducastelle-Lepretre, Nathalie Bleyzac, Vincent Piriou, Isabelle Durieu

Ann Pharm Fr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung lesions.
Mickaël Roussotte, Mael Richard, Natacha Grienay Poletto, Yoann Roubertou, Marie Vangout, Isabelle Durieu

Rev Med Interne· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes associated with CD2 and CD25 expression on bone marrow mast cells in patients with systemic mastocytosis.
Julien Rossignol, Sophie Georgin-Lavialle, Danielle Canioni, Omer Beganovic, Chantal Brouzes, Isabelle Durieu

Haematologica· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Chronic Q fever. Literature review and a case report of culture negative spondylodiscitis].
Florentin Masoch, Yoann Roubertou, Claire Triffault-Fillit, Sibylle Guillou, Marie Meignien, Isabelle Durieu

Rev Med Interne· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed Comparative Evaluation of a Training Program Dedicated to Cystic Fibrosis Reference Centers: Protocol for the Pilot Implementation of Shared Decision-Making in the Treatment of Diabetes in Adult Patients With Cystic Fibrosis.
Nora Moumjid, Constance Gotte, Sophie Hommey, Stéphanie Poupon Bourdy, Julie Haesebaert, Isabelle Durieu

JMIR Res Protoc· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of carbapenemase-producing Enterobacteriaceae reservoirs in wet hospital environments as a potential factor in patient acquisition: A cross-sectional study in a French university hospital in 2023.
Léna Sleiman, Cédric Dananché, Sophie Gardes, Isabelle Fredenucci, Camille Duval, Isabelle Durieu

Infect Dis Now· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study.
Pierre-Régis Burgel, Isabelle Sermet-Gaudelus, Emmanuelle Girodon, Isabelle Durieu, Véronique Houdouin

Lancet Respir Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurin.
Maël Heiblig, Clément Gourguechon, Philippe Guilpain, Cristina Bulai-Livideanu, Stéphane Barete, Isabelle Durieu

Am J Hematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One year of ETI reduces lung bacterial colonisation in adults with cystic fibrosis.
Lucile Mianowski, Anne Doléans-Jordheim, Laurent Barraud, Muriel Rabilloud, Mael Richard, Isabelle Durieu

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney effects of triple CFTR modulator therapy in people with cystic fibrosis.
Pierre Gabai, Etienne Novel-Catin, Quitterie Reynaud, Raphaële Nove-Josserand, Solenne Pelletier, Isabelle Durieu

Clin Kidney J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ophthalmic vascular manifestations in eosinophil-associated diseases: a comprehensive analysis of 57 patients from the CEREO and EESG networks and a literature review.
Elisa Chapuis, Elodie Bousquet, Jean-François Viallard, Benjamin Terrier, Zahir Amoura, Isabelle Durieu

Front Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis